The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced prices on 10 widely used, brand-name medications that are expensive and lack generic or biosimilar alternatives.

This article outlines the evolving rules surrounding Medicare telehealth coverage, highlighting key legislative changes and their impact on beneficiaries and health care providers. It clarifies which services are currently covered,